 |
Me too-drugs with limited benefits - the tale of regorafenib for HCC.
Nat Rev Clin Oncol. 2017 Nov 28;:
Authors: Gyawali B, Prasad V
Abstract
This corrects the article DOI: 10.1038/nrclinonc.2017.100.
PMID: 29182165 [PubMed - as supplied by publisher]
from #PM All via ola Kala on Inoreader http://ift.tt/2zBlLN4
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου